Supplement Industry

topic

The supplement industry operates under regulatory frameworks — DSHEA (Dietary Supplement Health and Education Act) in the US — that do not require pre-market safety or efficacy demonstration, allow structure/function claims without the evidence standards required for pharmaceutical claims, do not require reporting of adverse events, and produce a marketplace where contamination with unlisted active compounds (including pharmaceutical drugs, stimulants, and steroids in performance supplements), label inaccuracy (actual ingredient quantities differing from stated), and complete absence of clinical evidence are common findings in independent laboratory analysis.

Role

Supplement industry regulation is one of the most significant public health failures in modern consumer safety — producing a $150+ billion industry where the majority of products would not survive pharmaceutical regulatory review, where the marketing claims are systematically unsubstantiated by the scientific evidence required for pharmaceutical equivalents, and where the potential for harm (interactions with medications, undisclosed active compounds, contamination) exists alongside the pervasive assumption of safety that follows from products being sold in health food stores. The person who supplements with the same trust they apply to pharmaceutical medications is applying an inappropriate confidence level to an industry operating under dramatically weaker safety standards.

Explore "Supplement Industry" on the interactive map →